scholarly journals A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review

2022 ◽  
Vol Volume 15 ◽  
pp. 21-45
Author(s):  
Malik Sallam ◽  
Mariam Al-Sanafi ◽  
Mohammed Sallam
Keyword(s):  
Narrative Review ◽  
Vaccine Acceptance ◽  
Acceptance Rates

scholarly journals COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

Vaccines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 160
Author(s):  
Malik Sallam
Keyword(s):  
Middle East ◽  
General Public ◽  
Healthcare Workers ◽  
Decisive Role ◽  
Initial Step ◽  
Sub Saharan Africa ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
Republic Of The Congo ◽  
Acceptance Rates

Utility of vaccine campaigns to control coronavirus 2019 disease (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and healthcare workers appears to have a decisive role in the successful control of the pandemic. The aim of this review was to provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide. A systematic search of the peer-reviewed English survey literature indexed in PubMed was done on 25 December 2020. Results from 31 peer-reviewed published studies met the inclusion criteria and formed the basis for the final COVID-19 vaccine acceptance estimates. Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). However, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors and nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In the majority of survey studies among the general public stratified per country (29/47, 62%), the acceptance of COVID-19 vaccination showed a level of ≥70%. Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East and North Africa, Sub-Saharan Africa, Eastern Europe, Central Asia, Middle and South America. Addressing the scope of COVID-19 vaccine hesitancy in various countries is recommended as an initial step for building trust in COVID-19 vaccination efforts.

scholarly journals Hesitant or Not Hesitant? A Systematic Review on Global COVID-19 Vaccine Acceptance in Different Populations

Vaccines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 873
Author(s):  
Maria Giulia Salomoni ◽  
Zeno Di Valerio ◽  
Elisa Gabrielli ◽  
Marco Montalti ◽  
Dario Tedesco ◽  
...  
Keyword(s):  
Systematic Review ◽  
Geographical Origin ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
Public Health Systems ◽  
Pubmed Database ◽  
Collection Data ◽  
Different Populations ◽  
Acceptance Rates ◽  
Study Setting

Vaccination currently appears to be the only strategy to contain the spread of COVID-19. At the same time, vaccine hesitancy (VH) could limit its efficacy and has, therefore, attracted the attention of Public Health Systems. This systematic review aimed at assessing anti-COVID-19 vaccine acceptance rates worldwide and at identifying populations more prone to vaccine hesitancy, for which specific interventions should be planned. PubMed database was searched using a purposely formulated string. One hundred out of the 9243 studies retrieved were considered pertinent and thus included in the analyses. VH rate was analyzed according to patient geographical origin, ethnicity, age, study setting, and method used for data collection; data from specific populations were separately analyzed. Overall, this study demonstrated significant differences in terms of VH in the general population and in the specific subgroups examined according to geographical, demographic factors, as well as associated comorbidities, underlining the need for purposely designed studies in specific populations from the different countries, to design targeted programs aimed at increasing awareness for confidence and complacency toward COVID-19 vaccines.

scholarly journals Healthcare worker intentions to receive a COVID-19 vaccine and reasons for hesitancy: A survey of 16,158 health system employees on the eve of vaccine distribution

2020 ◽  
Author(s):  
Michelle N. Meyer ◽  
Tamara Gjorgjieva ◽  
Daniel Rosica
Keyword(s):  
Health System ◽  
Healthcare Workers ◽  
Response Rate ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
Population Immunity ◽  
Survey Results ◽  
Acceptance Rates ◽  
Vaccine Distribution ◽  
To Receive

AbstractHealthcare workers (HCWs) have been recommended to receive first priority for limited COVID-19 vaccines. They have also been identified as potential ambassadors of COVID-19 vaccine acceptance, helping to ensure that sufficient members of a hesitant public accept COVID-19 vaccines to achieve population immunity. Yet HCWs themselves have shown vaccine hesitancy in other contexts and the few prior surveys of U.S. HCW intentions to receive a COVID-19 vaccine report acceptance rates of only 28% to 34%. However, it is unknown whether HCW acceptance remains low following mid-November announcements of the efficacy of the first COVID-19 vaccines and the issuance of two emergency use authorizations (EUA) in December. We report the results of a December 2020 survey (N = 16,158; response rate 61%) administered by a large Pennsylvania health system to determine the intentions of its employees to receive a vaccine when it is offered to them. In a mixed sample of individuals serving in patient-facing and other roles, 55% would decide to receive a COVID-19 vaccine when offered, 16.4% would not, and 28.5% reported being undecided. The distribution of responses varied little across hospital campuses, between those in patient-facing roles and other HCWs, or by area or department of work. The higher rate of COVID-19 vaccine acceptance we observe may reflect the framing and timing of our survey. Among hesitant respondents, an overwhelming majority (90.3%) reported concerns about unknown risks and insufficient data. Other commonly reported concerns included known side effects (57.4%) and wanting to wait until they see how it goes with others (44.4%). We observed a substantial increase in self-reported intent to receive a COVID-19 vaccine after an FDA advisory committee voted to recommend an EUA. Among respondents who completed the survey after that point in time, 79% intend to receive a COVID-19 vaccine (n = 1155). Although only suggestive, this trend offers hope that rates of COVID-19 vaccine acceptance may be higher among HCWs and, perhaps, the general public than more hypothetical survey results have indicated.

scholarly journals Healthcare worker intentions to receive a COVID-19 vaccine and reasons for hesitancy: A survey of 16,158 health system employees on the eve of vaccine distribution

2020 ◽  
Author(s):  
Michelle N. Meyer ◽  
Tamara Gjorgjieva ◽  
Daniel Rosica
Keyword(s):  
Health System ◽  
Healthcare Workers ◽  
Response Rate ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
Population Immunity ◽  
Survey Results ◽  
Acceptance Rates ◽  
Vaccine Distribution ◽  
To Receive

Healthcare workers (HCWs) have been recommended to receive first priority for limited COVID-19 vaccines. They have also been identified as potential ambassadors of COVID-19 vaccine acceptance, helping to ensure that sufficient members of a hesitant public accept COVID-19 vaccines to achieve population immunity. Yet HCWs themselves have shown vaccine hesitancy in other contexts and the few prior surveys of U.S. HCW intentions to receive a COVID-19 vaccine report acceptance rates of only 28% to 34%. However, it is unknown whether HCW acceptance remains low following mid-November announcements of the efficacy of the first COVID-19 vaccines and the issuance of two emergency use authorizations (EUA) in December. We report the results of a December 2020 survey (N = 16,158; response rate 61%) administered by a large Pennsylvania health system to determine the intentions of its employees to receive a vaccine when it is offered to them. In a mixed sample of individuals serving in patient-facing and other roles, 55% would decide to receive a COVID-19 vaccine when offered, 16.4% would not, and 28.5% reported being undecided. The distribution of responses varied little across hospital campuses, between those in patient-facing roles and other HCWs, or by area or department of work. The higher rate of COVID-19 vaccine acceptance we observe may reflect the framing and timing of our survey. Among hesitant respondents, an overwhelming majority (90.3%) reported concerns about unknown risks and insufficient data. Other commonly reported concerns included known side effects (57.4%) and wanting to wait until they see how it goes with others (44.4%). We observed a substantial increase in self-reported intent to receive a COVID-19 vaccine after an FDA advisory committee voted to recommend an EUA. Among respondents who completed the survey after that point in time, 79% intend to receive a COVID-19 vaccine (n = 1155). Although only suggestive, this trend offers hope that rates of COVID-19 vaccine acceptance may be higher among HCWs and, perhaps, the general public than more hypothetical survey results have indicated.

scholarly journals STUDI CROSS-SECTIONAL: PERSEPSI MASYARAKAT TERHADAP PENERIMAAN VAKSINASI COVID-19 DI KABUPATEN KARANGASEM

2021 ◽  
Vol 5 (2) ◽  
pp. 150-158
Author(s):  
Ni Nyoman Ayu Ardiningsih ◽  
Made Pasek Kardiwinata
Keyword(s):  
Public Perception ◽  
Herd Immunity ◽  
College Education ◽  
Female Gender ◽  
Cross Sectional Study ◽  
Chi Square ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
Chi Square Test ◽  
Acceptance Rates

ABSTRAKLatar Belakang: Vaksinasi COVID-19 merupakan salah satu upaya untuk mengatasi pandemi COVID-19 yang terjadi saat ini. Tingkat penerimaan vaksinasi yang rendah dapat menghambat tercapainya herd immunity. Tujuan dari penelitian ini adalah untuk mengetahui gambaran persepsi masyarakat terhadap penerimaan vaksinasi COVID-19 di Kecamatan Karangasem Kabupaten Karangasem.Metode: Desain penelitian studi cross-sectional dengan populasi masyarakat Kecamatan Karangasem berusia 18-59 tahun. Besar sampel 184 orang didapat dengan teknik voluntary sampling. Data dikumpulkan secara online menggunakan google form. Analisis data menggunakan uji chi-square.Hasil: penerimaan vaksinasi sebesar 96,20% dan 3,80% menolak karena memiliki riwayat penyakit komorbid. Variabel yang berhubungan signifikan dengan penerimaan vaksinasi COVID-19 adalah jenis kelamin perempuan (OR=1,62; 95% CI 0,26-11,32), usia lebih dari 55 tahun (OR=3,42; 95% CI 0,44-26,59), pendidikan terakhir perguruan tinggi (OR=11,41; 95% CI 1,32-529,13), persepsi kerentanan terinfeksi COVID-19 yang tinggi (OR=7,79; 95% CI 1,20-83,41), persepsi keparahan terinfeksi COVID-19 yang tinggi (OR=4,37, 95% CI 0,67-46,07), persepsi manfaat vaksinasi COVID-19 yang tinggi (OR=7,79; 95% CI 1,20-83,41), dan persepsi hambatan melakukan vaksinasi yang rendah (OR=5,73; 95% CI 0,10-64,08).Kesimpulan: penelitian selanjutnya perlu untuk mengkaji terkait penyakit komorbid terhadap penerimaan vaksin COVID-19.Kata kunci: COVID-19, penerimaan vaksin, KarangasemABSTRACTBackground: The COVID-19 vaccination is one of the efforts to overcome the current COVID-19 pandemic. Low vaccination acceptance rates can hinder the achievement of herd immunity. The purpose of this study was to describe the public perception of receiving COVID-19 vaccination in the Sub-district of Karangasem, Karangasem Regency.Methods: The design of study used a cross-sectional study with the population of Karangasem Sub-district aged 18-59 years. The sample size of 184 people was obtained by voluntary sampling. Data collected online using google form. Chi-square test were used for data analysis.Results: vaccine acceptance rate was 96.20% and 3,80% refuse to get vaccine because they have comorbid. Variables that have a significant associate to the acceptance of COVID-19 vaccination are female gender (OR=1,62; 95% CI 0,26-11,32), age more than 55 years (OR=3,42; 95% CI 0,44-26,59), last college education (OR=11,41; 95% CI 1,32-529,13), high perceived of susceptibility to COVID-19 infection (OR=7,79; 95% CI 1,20-83,41), high perceived of severity if infected with COVID-19 (OR=4,37, 95% CI 0,67-46,07), high perceived benefits of COVID-19 vaccination (OR=7,79; 95% CI 1,20-83,41), and low perceived barriers to vaccination (OR=5,73; 95% CI 0,10-64,08).Conslusion: Further research need to study related comorbid to COVID-19 vaccine acceptance.Keyword: COVID-19, vaccine acceptance, Karangasem

scholarly journals Achieving High Coverage of H1N1 Influenza Vaccine in an Ethnically Diverse Obstetric Population: Success of a Multifaceted Approach

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Kara K. Hoppe ◽  
Linda O. Eckert
Keyword(s):  
Vaccine Coverage ◽  
Ethnically Diverse ◽  
H1n1 Influenza ◽  
Vaccine Uptake ◽  
High Coverage ◽  
H1n1 Vaccine ◽  
Vaccine Acceptance ◽  
Multifaceted Approach ◽  
Acceptance Rates ◽  
Obstetric Population

Objective. To report on a multifaceted approach to increase uptake of the H1N1 vaccine in our ethnically diverse obstetrical population.Methods. A review of our obstetric clinic vaccine registry and the approaches used to increase vaccine uptake. We created a real-time vaccine registry, educated patients in their own language via educational videos and use of cultural case workers, facilitated patient appointments and transportation, educated staff, and used other interventions to enhance immunization uptake.Results. Within the first month of H1N1 availability, we vaccinated 120 of our total 157 obstetrics patients. Our overall coverage rate was 76% (number vaccinated/total number eligible.) Of the enrolled patients, the vaccine acceptance rates were similar in our English (59 (78%) of 76) versus non-English (59 (75%) of 79) speaking patients.Conclusions. High vaccine coverage is possible in an ethnically diverse, highly immigrant obstetrics population.

scholarly journals COVID-19 vaccine hesitancy worldwide: a systematic review of vaccine acceptance rates

2021 ◽  
Author(s):  
Malik Sallam
Keyword(s):  
Middle East ◽  
General Public ◽  
Healthcare Workers ◽  
Decisive Role ◽  
Survey Study ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
East Russia ◽  
Republic Of The Congo ◽  
Acceptance Rates

AbstractIntroductionUtility of vaccine campaigns to control coronavirus disease 2019 (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and the healthcare workers, appears to have a decisive role for successful control of the pandemic.AimTo provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide.MethodsA systematic search of the peer-reviewed English survey literature indexed in PubMed was done on December 25, 2020. Results from 30 studies, met the inclusion criteria and formed the basis for final COVID-19 vaccine acceptance estimates. Results of an additional recent survey from Jordan and Kuwait was considered in this review as well.ResultsSurvey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). On the other hand, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors, nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In a majority of survey studies among the general public (62%), the acceptance of COVID-19 vaccination showed a level of ≥ 70%.ConclusionsLow rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts that aim to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East Africa, Eastern Europe, Central Asia, Middle and Latin America.Graphical AbstractCOVID-19 vaccine acceptance rates worldwideFor countries with more than one survey study, the vaccine acceptance rate of the latest survey was used in this graph. The estimates were also based on studies from the general population, except in the following cases were no studies from the general public were found (Australia: parents/guardians; DRC: healthcare workers; Hong Kong: healthcare workers; Malta: healthcare workers).

scholarly journals COVID-19 Vaccine Hesitancy Worldwide: A Systematic Review of Vaccine Acceptance Rates

2020 ◽  
Author(s):  
Malik Sallam
Keyword(s):  
Middle East ◽  
General Public ◽  
Healthcare Workers ◽  
Decisive Role ◽  
Vaccine Hesitancy ◽  
Vaccine Acceptance ◽  
Vaccination Acceptance ◽  
East Russia ◽  
Republic Of The Congo ◽  
Acceptance Rates

Utility of vaccine campaigns to control coronavirus disease 2019 (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and the healthcare workers, appears to have a decisive role for successful control of the pandemic. The aim of this review was to provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide. A systematic search of the peer-reviewed English survey literature indexed in PubMed was done on December 25, 2020. Results from 30 studies, met the inclusion criteria and formed the basis for final COVID-19 vaccine acceptance estimates. Results of an additional recent survey from Jordan and Kuwait was considered in this review as well. Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). On the other hand, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors, nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In a majority of survey studies among the general public (62%), the acceptance of COVID-19 vaccination showed a level of ≥ 70%. Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts that aim to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East Africa, Eastern Europe, Central Asia, Middle and Latin America.

scholarly journals Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America

Narra J ◽  
2021 ◽  
Vol 1 (3) ◽  
Author(s):  
Dott F. Rosiello ◽  
Samsul Anwar ◽  
Amanda Yufika ◽  
Rashed Y. Adam ◽  
Mohajer IH. Ismaeil ◽  
...  
Keyword(s):  
Side Effects ◽  
Online Survey ◽  
Vaccine Safety ◽  
Vaccine Hesitancy ◽  
South American ◽  
Efficacy And Safety ◽  
African Countries ◽  
Vaccine Acceptance ◽  
Safety And Efficacy ◽  
Acceptance Rates

Vaccine hesitancy, defined as the reluctance or rejection in receiving a vaccine despite its availability, represents a major challenge to global health efforts aiming to control the ongoing COVID-19 pandemic. Understanding the possible factors correlated with COVID-19 vaccine hesitancy using a refined well-informed approach can be helpful to address the phenomenon. The current study aimed to evaluate COVID-19 vaccine acceptance rates using four hypothetical scenarios of varying levels of vaccine efficacy and safety profiles in ten Asian, African and South American countries. These scenarios included: 95% efficacy and 20% side effects (Vaccine A), 75% efficacy and 5% side effects (Vaccine B); 75% efficacy and 20% side effects (Vaccine C) and 50% efficacy and 5% side effects (Vaccine D). This study used a self-administered online survey that was distributed during February–May 2021. The total number of study respondents was 1337 with countries of residence as follows: India (21.1%), Pakistan (12.9%), Sudan (11.2%), Nigeria (9.3%), Iran (8.2%), Bangladesh and Brazil (7.9%), Chile (7.7%), Tunisia (7.6%), and Egypt (6.2%). The overall acceptance rates for COVID-19 vaccination were variable based on varying degrees of safety and efficacy as follows: 55.6% for Vaccine C, 58.3% for Vaccine D, 74.0% for Vaccine A and 80.1% for Vaccine B. The highest levels of COVID-19 vaccine acceptance were observed in Brazil followed by Chile across the four different safety and efficacy scenarios. The lowest COVID-19 vaccine acceptance rates were reported in Egypt and Tunisia for the low safety scenarios (20% side effects), and the low efficacy scenario (50% efficacy). The study revealed the potential effect of vaccine safety and efficacy on the intention to get COVID-19 vaccination. At the same efficacy level, higher possibility of side effects caused a large drop in COVID-19 vaccine acceptance rate. This indicates the importance of accurate communication regarding vaccine safety and efficacy on attitude towards the vaccine and intentions to get vaccinated. Regional differences in COVID-19 vaccine acceptance were observed with the Middle East/North African countries showing the lowest rates and the South American countries displaying the highest vaccine acceptance rates.

Sign in / Sign up

Export Citation Format

Share Document